The approval by the US Food Drug Administration (USFDA) for the abbreviated new drug application (ANDA) Rivaroxaban tablet is for multiple strengths of 10 mg, 15 mg, and 20 mg, Alembic Pharmaceuticals said in a regulatory filing.from Moneycontrol Business News https://ift.tt/2NmnsXa
No comments:
Post a Comment